The U.S. Food and Drug Administration approved Giapreza (angiotensin II) injection for intravenous infusion to increase Blood Pressure in adults with septic or other distributive shock. “Shock, the inability to maintain blood flow to vital tissues, can result in organ failure and death,” said Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiovascular and […]